Mol-CycleGAN – a generative model for molecular optimization

Topic:

Designing a molecule with desired properties is one of the biggest challenges in drug development, as it requires optimization of chemical compound structures with respect to many complex properties. To augment the compound design process we introduce Mol-CycleGAN – a CycleGAN-based model that generates optimized compounds with high structural similarity to the original ones. Namely, given a molecule our model generates a structurally similar one with an optimized value of the considered property. We evaluate the performance of the model on selected optimization objectives related to structural properties (presence of halogen groups, number of aromatic rings) and to a physicochemical property (penalized logP). In the task of optimization of penalized logP of drug-like molecules our model significantly outperforms previous results.

Read more

https://arxiv.org/pdf/1902.02119.pdf

You might be also interested in:

Can AI Stop the Cost Spiral in Drug Discovery? Summary of Our Expert Talk at BioTech X 2025
Your monthly AI in biotech digest – October
Abstract visualization of AI-driven analysis of patient data, representing precision medicine and responder identification.
Precision Trials: Using AI to Identify Responders
Poster: Safer pHLA-Targeted Immunotherapies Through AI and Computational Immunology

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!